findmyKOL
Clinical trialNCT05758688RecruitingPhase 2Interventional

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

SponsorAbramson Cancer Center at Penn MedicineEnrollment25Cervical CancerEndometrial CancerUterine Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-reported gastrointestinal (GI) toxicity using WP PBS PRT in the definitive treatment of gynecologic cancers in the post-surgical, adjuvant setting.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Virtua Health

    Voorhees Township, New Jersey, United States

    Graeme Williams, MD, MBA
    Recruiting
  • Lancaster General Health - Ann B. Barshinger Cancer Institute

    Lancaster, Pennsylvania, United States

    Pamela Boimel, MD, PhD
    Recruiting
  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Neil K Taunk, MD, MSCTS
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Nov 2023
Primary completion
30 Nov 2026
Completion
31 Dec 2026
Last update posted
10 Jun 2026
Registered enrollment
25
Registry id
NCT05758688

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.